Thank you for your question.
My organization isn't involved in facilitating commercialization. Rather, it's facilitating conversations between the different stakeholders involved. We actually try to highlight with our publications, which are all free and accessible online, the work of indigenous scholars and activists and researchers and people from the global south.
I think in this conversation this is what's most interesting to me—the different ways we can find to protect indigenous knowledge and the plant medicines from being exploited, commodified or commercialized in a way that would result in a lack of fair compensation to the communities involved. Those are things like anti-patent strategies or liberatory licences or IP abolition or, in the context of the United States, to look at the different protections there are for religious use, which can sometimes trump commercial, clinical or medical contexts and also allow for a greater protection for a more diverse range of different cultures and communities that might be using these compounds.